Tetra Discovery

About:

Tetra Discovery provides consulting services and research on drug discovery for diseases affecting the central nervous system.

Website: http://tetradiscovery.com

Twitter/X: TetraDiscovery

Top Investors: Biosciences Research and Commercialization Center (BRCC), Michigan.com, Dolby Family Ventures, Michigan Emerging Technology Fund, Muskegon Angels

Description:

Tetra Discovery Partners provides consulting services in drug discovery and development. They partner with Universities to commercialize intellectual property and conduct proprietary research on diseases affecting the central nervous system. Their research focuses on developing new treatments for depression and schizophrenia. Severe forms of depression affect 2–5% of the US population, while mood disorders impact 7% of the world’s population and rank among the top ten causes of disability.

Total Funding Amount:

$12.5M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Grand Rapids, Michigan, United States

Founded Date:

2010-01-01

Contact Email:

info(AT)tetradiscovery.com

Founders:

Mark Gurney

Number of Employees:

1-10

Last Funding Date:

2016-11-29

IPO Status:

Private

Industries:

© 2025 bioDAO.ai